Literature DB >> 12861107

Overnight orthokeratology: visual and corneal changes.

P Sarita Soni1, Tracy T Nguyen, Joseph A Bonanno.   

Abstract

PURPOSE: To achieve an optimal fit with reverse geometry Contex OK lenses and to determine a time course for and the stability of visual and corneal changes in achieving maximal refractive, corneal curvature, and corneal thickness changes after overnight wear of OK B and D series lenses.
METHODS: This investigation was conducted under an Food and Drug Administration IDE G000059. Both eyes of 10 subjects were fitted with the lenses, and uncorrected visual acuity, refractive correction, contrast sensitivity, corneal curvature, and corneal thickness were measured at baseline and at 1 day, 1week, 1 month, and 3 months after lenses were worn. Except for baseline, data were collected at four different times during the day, immediately following lens removal and 4, 8, and 12 hours after lens removal.
RESULTS: The results from eight subjects showed that uncorrected visual acuity, refractive correction, contrast sensitivity, and corneal curvature all changed significantly (P=0.01) overnight. By the end of 1 week, all corneal and visual changes had reached a maximal level and remained fairly stable during the day. These changes were sustained at 3 months. The epithelial thickness data from four subjects showed that the corneal epithelial thickness was reduced by approximately 19 microm after 3 months of lens wear.
CONCLUSIONS: Successful fitting of OK B and D series lenses requires a thorough understanding of the lens-cornea relationship. Full effect of overnight orthokeratology is achieved by the end of 1 week. The visual and corneal changes remain stable for all waking hours of the day and allow patients to enjoy excellent device-free vision (20/20).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12861107     DOI: 10.1097/01.ICL.0000072831.13880.A0

Source DB:  PubMed          Journal:  Eye Contact Lens        ISSN: 1542-2321            Impact factor:   2.018


  8 in total

1.  A prospective interventional study of effect of accelerated orthokeratology on the corneal curvature and refraction among young adults with myopia.

Authors:  M A Khan; Ashutosh Gupta; T S Ahluwalia; P S Moulick; V S Gurunadh; Sandeep Gupta
Journal:  Med J Armed Forces India       Date:  2016-04-16

2.  Peripheral optics with bifocal soft and corneal reshaping contact lenses.

Authors:  Anita Ticak; Jeffrey J Walline
Journal:  Optom Vis Sci       Date:  2013-01       Impact factor: 1.973

3.  [Corneal changes after wearing orthokeratology contact lenses: an investigation using in vivo, confocal laser scanning microscopy].

Authors:  S Knappe; O Stachs; R Guthoff
Journal:  Ophthalmologe       Date:  2007-08       Impact factor: 1.059

4.  Changes and Diurnal Variation of Visual Quality after Orthokeratology in Myopic Children.

Authors:  Hao-Chen Guo; Wan-Qing Jin; An-Peng Pan; Qin-Mei Wang; Jia Qu; A-Yong Yu
Journal:  J Ophthalmol       Date:  2018-10-15       Impact factor: 1.909

5.  The Topographical Effect of Optical Zone Diameter in Orthokeratology Contact Lenses in High Myopes.

Authors:  G Carracedo; T M Espinosa-Vidal; I Martínez-Alberquilla; L Batres
Journal:  J Ophthalmol       Date:  2019-01-02       Impact factor: 1.909

6.  The effect of orthokeratology treatment zone decentration on myopia progression.

Authors:  Lu Sun; Zheng-Xuan Li; Yun Chen; Zhi-Qiang He; Hong-Xin Song
Journal:  BMC Ophthalmol       Date:  2022-02-15       Impact factor: 2.209

7.  Refractive error, visual acuity, and corneal-curvature changes in high and low myopes with orthokeratology treatment: A Malaysian study.

Authors:  Swee Lee Liong; Norhani Mohidin; Bay Wah Tan; Bariah Mohd Ali
Journal:  Taiwan J Ophthalmol       Date:  2015-09-12

8.  The Synergistic Effects of Orthokeratology and Atropine in Slowing the Progression of Myopia.

Authors:  Lei Wan; Chang-Ching Wei; Chih Sheng Chen; Ching-Yao Chang; Chao-Jen Lin; Jamie Jiin-Yi Chen; Peng-Tai Tien; Hui-Ju Lin
Journal:  J Clin Med       Date:  2018-09-07       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.